The US Food and Drug Administration (FDA) has approved the expansion of BiVACOR’s early ... The decision follows five positive early implants, all of which US-based BiVACOR said had been ...

In 2022, the brain implants market was valued at over USD 5.7 billion, and its rapid expansion is fueled by several key factors. One of the most significant drivers is the rising incidence of nervous ...

Implantica's lead product, RefluxStop™, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported ...

The Smart Medical Implants Market was valued at US$ 5.7 Bn in 2022 and is projected to grow at a CAGR of 18.1% from 2023 to ...